Hologic, Inc. et al v. Minerva Surgical, Inc.

  1. August 28, 2020

    Hologic Gets NovaSure Patent Judgment Bumped Up To $7M

    A Delaware federal court on Friday approved a $2 million increase to a patent infringement judgment against Minerva Surgical Inc., saying Hologic Inc. is entitled to roughly $7 million for damages related to infringement of its endometrial ablation treatment NovaSure.

  2. May 02, 2019

    Minerva's Retrial Bid Nixed In NovaSure Patent Fight

    Minerva Surgical Inc.'s attempt to revisit a $5 million patent infringement judgment from a Delaware jury failed Thursday when the judge overseeing the case said the jury's decision was supported by evidence presented during a 10-day trial last year.

  3. July 30, 2018

    Jury Awards Hologic $5M For NovaSure Patent Infringement

    A Delaware federal jury on Friday said Minerva Surgical Inc. should pay Hologic Inc. $4.8 million for infringing a patent covering the endometrial ablation treatment NovaSure, but lessened the blow by finding the infringement wasn't willful.

  4. December 15, 2017

    PTAB Invalidates Hologic Patent, Rejects Claim Fixes

    The Patent Trial and Appeal Board on Friday found a Hologic Inc. medical device patent was invalid and rejected a series of proposed substitute claims, following a recent Federal Circuit ruling many believed gave patent owners a better chance at amending patents in America Invents Act reviews.